AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.70 and traded as high as $3.80. AIkido Pharma shares last traded at $3.58, with a volume of 4,244,921 shares changing hands.
AIkido Pharma Trading Up 57.7 %
The stock has a fifty day moving average of $1.48 and a 200-day moving average of $1.70. The firm has a market capitalization of $19.64 million, a price-to-earnings ratio of -0.92 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Featured Stories
- Five stocks we like better than AIkido Pharma
- What Are Dividend Champions? How to Invest in the Champions
- Nebius Group: Market Overreaction or Real AI Disruption?
- How Investors Can Find the Best Cheap Dividend Stocks
- The Best Way to Invest in Gold Is…
- What is a SEC Filing?
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
